Annual long term liabilities:
$70.92M+$70.88M(+191562.16%)Summary
- As of today (September 16, 2025), SPRY annual total long term liabilities is $70.92 million, with the most recent change of +$70.88 million (+191562.16%) on December 31, 2024.
- During the last 3 years, SPRY annual long term liabilities has fallen by -$13.61 million (-16.10%).
- SPRY annual long term liabilities is now -16.10% below its all-time high of $84.53 million, reached on December 31, 2021.
Performance
SPRY Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$75.55M+$4.83M(+6.83%)Summary
- As of today (September 16, 2025), SPRY quarterly total long term liabilities is $75.55 million, with the most recent change of +$4.83 million (+6.83%) on June 30, 2025.
- Over the past year, SPRY quarterly long term liabilities has increased by +$75.55 million (+100.00%).
- SPRY quarterly long term liabilities is now -10.62% below its all-time high of $84.53 million, reached on December 1, 2021.
Performance
SPRY quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SPRY Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +100.0% |
| 3 y3 years | -16.1% | -8.6% |
| 5 y5 years | +2033.4% | - |
SPRY Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | -16.1% | >+9999.0% | -10.6% | >+9999.0% |
| alltime | all time | -16.1% | >+9999.0% | -10.6% | >+9999.0% |
SPRY Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $75.55M(+6.8%) |
| Mar 2025 | - | $70.72M(-0.3%) |
| Dec 2024 | $70.92M(>+9900.0%) | $70.92M(>+9900.0%) |
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $37.00K(-98.8%) | $37.00K(-59.8%) |
| Sep 2023 | - | $92.00K(-37.0%) |
| Jun 2023 | - | $146.00K(-26.6%) |
| Mar 2023 | - | $199.00K(>+9900.0%) |
| Dec 2022 | $3.10M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $82.62M(+1764.6%) |
| Mar 2022 | - | $4.43M(-94.8%) |
| Dec 2021 | $84.53M(+162.1%) | - |
| Dec 2021 | - | $84.53M(+1563.9%) |
| Sep 2021 | - | $5.08M(+185.7%) |
| Jun 2021 | - | $1.78M(-13.5%) |
| Mar 2021 | - | $2.06M(-11.7%) |
| Dec 2020 | $32.25M(+870.2%) | $2.33M(-30.0%) |
| Dec 2019 | $3.32M(-21.0%) | $3.32M |
| Dec 2018 | $4.21M | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is ARS Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of SPRY is $70.92M
What is the all time high annual long term liabilities for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual total long term liabilities is $84.53M
What is ARS Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, SPRY annual total long term liabilities has changed by +$70.88M (+191562.16%)
What is ARS Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of SPRY is $75.55M
What is the all time high quarterly long term liabilities for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $84.53M
What is ARS Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, SPRY quarterly total long term liabilities has changed by +$75.55M (+100.00%)